Nephropathy

(redirected from nephropathic)
Also found in: Dictionary, Thesaurus, Medical.

nephropathy

[nə′fräp·ə·thē]
(medicine)
Any disease of the kidney.

Nephropathy

 

a general term that includes several renal disorders. Classified as nephropathies are nephropathy of pregnancy and a group of other kidney diseases that are distinguished from each other by a variety of morphological changes. This latter group of diseases includes myelogenous nephropathy, endemic, or Balkan, nephropathy, medicinally induced nephropathy, kaliopenic nephropathy, and hypercalcemic nephropathy.

REFERENCE

Osnovy nefrologii, vol. 2. Edited by E. M. Tareev. Moscow, 1972.
References in periodicals archive ?
Nephropathic or "classic infantile" cystinosis the most common and most severe form of the disease is typically diagnosed in infancy and requires lifelong cystine depleting therapy.
Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS).
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
Nephropathic cystinosis, an orphan disease, is estimated to effect a population of 2,000 patients worldwide, including 500 patients in the U.S.
According to the WHO life quality questionnaire, QOL is negatively affected in diabetic nephropathic patients with microalbuminuria (32).
Kaiser-Kupfer experienced success in reducing visual loss associated with the rare metabolic disorders gyrate atrophy and nephropathic cystinosis.
Benefits of Intensive Insulin Therapy Formerly on Formerly on Nephropathic Intensive Therapy Conventional Therapy Outcome (n = 687) (n = 688) Hypertension 29.9% 40.3% New-onset 6.8% 15.8% Microalbuminuria New-onset Clinical 1.4% 9.4% albuminuria Serum creatinine Of 0.7% 2.8% at least 2 mg/dL Note: Patients had similar suboptimal glycosylated hemoglobin levels during 8 years of follow-up in the EDIC study.
Benefits of Intesive Insulin Therapy Formerly on Formerly on Nephropathic Intensive Therapy Conventional Therapy Outcome (n = 687) (n = 688) Hypertension 29.9% 40.3% New-onset Microalbuminuria 6.8% 15.8% New-onset Clinical albuminuria 1.4% 9.4% Serum creatinine Of at least 2 mg/dL 0.7% 2.8% Note: Patients had similar suboptimal glycosylated hemoglobin levels during 8 years of follow-up in the EDIC study.
Benefits of Intensive Insulin Therapy Formerly on Formerly on Nephropathic Intensive Therapy Conventional Therapy Outcome (n = 687) (n = 688) Hypertension 29.9% 40.3% New-onset Microalbuminuria 6.8% 15.8% New-onset Clinical albuminuria 1.4% 9.4% Serum creatinine Of at least 2 mg/dL 0.7% 2.8% Note: Patients had similar suboptimal glycosylated hemoglobin levels during 8 years of follow-up in the EDIC study.
There are three types of cystinosis, which can appear at any age: infantile nephropathic (usually from 6-8 months after birth), late-onset nephropathic (usually between ages 12 and 13), and benign non-nephropathic (usually in adulthood).
Study 003 is a single arm, open label study designed to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneous (SC) ELX-02 in patients with nephropathic cystinosis with at least 1 nonsense mutation in the cystinosin gene.